Niagen Bioscience (NAGE) Profit After Tax (2010 - 2026)
Niagen Bioscience (NAGE) reported Profit After Tax of $6.3 million for Q1 2026, up 24.79% year-over-year from $5.1 million in Q1 2025, and up 54.78% quarter-over-quarter from $4.1 million in Q4 2025.
Niagen Bioscience (NAGE) Profit After Tax (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 17 years of Profit After Tax data on file, last reported at $6.3 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at $6.3 million, up 24.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.6 million (up 31.78% YoY), and the FY2025 annual result was $17.4 million, up 103.3% from the prior year.
- Profit After Tax advanced to $6.3 million in Q1 2026 per NAGE's latest filing, from $4.1 million in the prior quarter.
- Over five years, Profit After Tax peaked at $7.2 million in Q4 2024 and troughed at -$7.7 million in Q1 2022.
- A 5-year average of $630705.9 and a median of -$15000.0 in 2024 frame the typical range for Profit After Tax.
- On a YoY basis, Profit After Tax climbed as much as 24160.0% in 2025 and fell as far as 43.14% in 2025.
- A 5-year view of Profit After Tax shows it stood at -$1.4 million in 2022, then jumped by 108.04% to $114000.0 in 2023, then surged by 6197.37% to $7.2 million in 2024, then slumped by 43.14% to $4.1 million in 2025, then surged by 54.78% to $6.3 million in 2026.
- Business Quant data shows NAGE's Profit After Tax at $6.3 million in Q1 2026, $4.1 million in Q4 2025, and $4.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.74 Mn |
| 10 | Niagen Bioscience | 269.32 Mn | 202.77 Mn | 19.98 Mn | 6.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.32 Mn |
| Dec 31, 2025 | 4.08 Mn |
| Sep 30, 2025 | 4.58 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | 7.18 Mn |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -492,000.00 |
| Dec 31, 2023 | 114,000.00 |
| Sep 30, 2023 | -959,000.00 |
| Jun 30, 2023 | -2.19 Mn |
| Mar 31, 2023 | -1.90 Mn |
| Dec 31, 2022 | -1.42 Mn |
| Sep 30, 2022 | -985,000.00 |
| Jun 30, 2022 | -6.40 Mn |
| Mar 31, 2022 | -7.74 Mn |
| Dec 31, 2021 | -5.33 Mn |
| Sep 30, 2021 | -8.86 Mn |
| Jun 30, 2021 | -5.57 Mn |